Oncology studies often have unique qualities that complicate budgeting and forecasting. Modelling various patient cohorts, complex treatments, adaptive trial designs, and timing the enrollment and costing of the study can be tricky, at best.
Learn some of the top considerations for budgeting oncology studies and tips for how to approach these challenges from our panel of biopharmaceutical professionals. We will discuss topics such as options to react more quickly to protocol amendments, planning for study extensions, and utilizing benchmarks to ensure you get competitive market pricing for outsourced services and their experiences of using various tactics and tools.
Help to improve your organization’s oncology trial agility by implementing accurate budgeting and planning with speed and learning from these real-world examples.